의료 관련 주식
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3257 |  CLPT ClearPoint Neuro Inc. - Common Stock | 9.64 USD | +4.33% | -7.75% | -29.38% | -61.14% | 294.06 M USD | ||
| 3275 |  QSI Quantum-Si Incorporated - Class A Common Stock | 1.31 USD | -5.76% | +3.97% | +74.67% | -44.96% | 286.74 M USD | ||
| 3281 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 8.33 USD | -4.14% | -11.00% | -28.56% | -43.33% | 284.61 M USD | ||
| 3295 |  ONMD OneMedNet Corp - Class A Common Stock | 4.75 USD | +0.85% | -2.06% | +666.13% | +85.55% | 281.61 M USD | ||
| 3298 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.67 USD | 0.00% | -2.13% | -3.67% | -59.89% | 280.01 M USD | ||
| 3304 |  INFU InfuSystems Holdings, Inc. Common Stock | 13.91 USD | +2.13% | +3.50% | +10.84% | +79.48% | 277.05 M USD | ||
| 3305 |  ANIK Anika Therapeutics Inc. - Common Stock | 20.69 USD | +2.17% | +6.81% | -1.66% | +104.04% | 276.89 M USD | ||
| 3309 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.16 USD | 0.00% | +13.09% | +113.86% | +107.69% | 274.87 M USD | ||
| 3310 |  OCGN Ocugen, Inc. - Common Stock | 0.81 USD | -3.57% | -16.49% | -20.59% | -49.06% | 274.68 M USD | ||
| 3320 |  IPSC Century Therapeutics, Inc. - Common Stock | 1.50 USD | +8.70% | +2.74% | -20.63% | +167.86% | 271.61 M USD | ||
| 3322 |  EYPT EyePoint, Inc. - Common Stock | 3.14 USD | +4.32% | -7.65% | -10.80% | -73.83% | 270.71 M USD | ||
| 3324 |  PALI Palisade Bio, Inc. - Common Stock | 1.54 USD | +4.05% | +3.36% | -12.00% | -9.41% | 268.38 M USD | ||
| 3325 |  CATX Perspective Therapeutics, Inc. Common Stock | 2.35 USD | +5.86% | -13.28% | -14.86% | -50.53% | 268.26 M USD | ||
| 3327 |  TMCI Treace Medical Concepts, Inc. - Common Stock | 4.12 USD | +1.98% | +6.19% | -11.59% | -35.02% | 267.94 M USD | ||
| 3332 |  ABEO Abeona Therapeutics Inc. - Common Stock | 4.65 USD | +6.65% | -5.87% | -18.28% | -13.89% | 265.91 M USD | ||
| 3333 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 3.32 USD | +2.79% | -14.21% | -30.69% | +155.38% | 264.95 M USD | ||
| 3339 |  CABA Cabaletta Bio, Inc. - Common Stock | 1.55 USD | -4.32% | -20.10% | -38.98% | -45.61% | 262.80 M USD | ||
| 3340 |  OSUR OraSure Technologies, Inc. - Common Stock | 3.81 USD | +2.70% | +0.79% | +8.24% | +24.92% | 262.77 M USD | ||
| 3345 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 2.64 USD | +7.76% | -6.71% | -25.84% | -11.11% | 261.75 M USD | ||
| 3348 |  BDSX Biodesix, Inc. - Common Stock | 24.71 USD | +3.00% | -6.22% | -14.76% | +97.52% | 260.72 M USD |
뉴스 의료 관련 주식
UBS, 솔리드 바이오사이언스 투자의견 ‘매수’로 신규 개시···목표주가 20달러 제시
매크로제닉스, 진행성 고형암 환자 대상 비공개 표적 항체-약물 접합체 MGC030의 1상 임상시험에서 첫 환자 투여
목요일 장중 변동한 12개 헬스케어 주식
다이애딕 인터내셔널 13G 공시: 엠퍼리 에셋 매니지먼트, 9월 30일 기준 8.35% 지분 보유 보고
뉴라시스, 의료 정책 적용 범위가 2,600만 명 이상의 의료 보험 가입자에게 확대되었다고 발표
에데사 바이오테크, 백반증 치료제 EB06의 2상 임상시험을 위한 신약 임상시험계획(IND) 신청에 대해 FDA 승인 획득
렉사리아 바이오사이언스, 디하이드라테크-CBD 조성물 및 디하이드라테크-세마글루타이드 모두 평가한 동물실험 GLP-1-A26-1 결과 발표···아쉽게도 뇌 조직 내 DHT-SEMA 농도는 본 연구에 사용된 생물학적 분석의 정량 하한선 이하 수준
Gainers 의료 관련 주식
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Losers 의료 관련 주식
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |